Dechra Pharmaceuticals (DPH) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Dechra Pharmaceuticals PLC (DPH.L)February 15, 2024 | finance.yahoo.comDechra Pharmaceuticals Stock (OTC:DPHAY) Dividends: History, Yield and DatesFebruary 11, 2024 | benzinga.comForm 8.3 - Dechra Phartmaceuticals PLC - AmendmentJanuary 15, 2024 | finance.yahoo.comUK's Hargreaves says Dechra's Platt to succeed Oppenheimer as chairNovember 29, 2023 | msn.comForm 8.3 - DPH LN Equity 09-November-23 Decrease in Traded Position DisclosureNovember 10, 2023 | finance.yahoo.comDechra Pharmaceuticals PLC DPHNovember 9, 2023 | morningstar.comForm 8.3 - DPH LN Equity 01-November-23 Decrease in Traded Position DisclosureNovember 2, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 30-October-23 Decrease in Traded Position DisclosureOctober 31, 2023 | finance.yahoo.comMagnetar Capital Partners LP - Form 8.3 - Dechra Pharmaceuticals plcOctober 30, 2023 | finanznachrichten.deForm 8.3 - DPH LN Equity 23-October-23 Increase in Traded Position DisclosureOctober 24, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 17-October-23 Increase in Traded Position DisclosureOctober 18, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 28-September-23 Increase in Traded Position AmendmentOctober 12, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 03-October-23 Decrease in Traded Position AmendmentOctober 12, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 05-October-23 Dealing Disclosure - AmendmentOctober 12, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 10-October-23 Decrease in Traded Position DisclosureOctober 11, 2023 | finance.yahoo.comPrivate equity ‘vultures’ feast on beleaguered public marketsOctober 4, 2023 | proactiveinvestors.comForm 8.3 - DPH LN Equity 28-September-23 Dealing DisclosureSeptember 29, 2023 | finance.yahoo.comDechra Pharmaceuticals falls Thursday, still outperforms marketSeptember 21, 2023 | marketwatch.comForm 8.3 - Dechra Pharmaceuticals plc - AmendmentSeptember 20, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 14-September-23 Dealing DisclosureSeptember 15, 2023 | finance.yahoo.comBack in the Big League: M&S Rejoins the FTSE 100 on Share Price BoostAugust 31, 2023 | markets.businessinsider.comMarks & Spencer Set for FTSE 100 Comeback After This Year’s 78% Share Price RiseAugust 22, 2023 | finance.yahoo.comDechra Pharmaceuticals remains steady Tuesday, still outperforms marketAugust 15, 2023 | marketwatch.comDechra Pharmaceuticals PLC (LON:DPH) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Dechra Pharmaceuticals PLC (LON:DPH - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the six ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating toAugust 8, 2023 | marketbeat.comDPH: Carlson Capital, L.P.: Form 8.3 - Dechra Pharmaceuticals plcJuly 20, 2023 | bloomberg.comForm 8.3 - DPH LN Equity 11-July-23 Increase in Traded PositionJuly 12, 2023 | finance.yahoo.comDechra Pharmaceuticals remains steady Thursday, still outperforms marketJuly 6, 2023 | marketwatch.comDCHPF - Dechra Pharmaceuticals PLCJuly 6, 2023 | finance.yahoo.comDechra Pharmaceuticals outperforms market despite losses on the dayJuly 5, 2023 | marketwatch.comForm 8.3 - DPH LN Equity 30-June-23 Increase in Traded PositionJuly 3, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 27-June-23 Dealing DisclosureJune 28, 2023 | finance.yahoo.comDechra Pharmaceuticals PLC (LON:DPH) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Dechra Pharmaceuticals PLC (LON:DPH - Get Rating) have been given an average recommendation of "Moderate Buy" by the six ratings firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy rJune 19, 2023 | marketbeat.comForm 8.3 - Dechra Pharmaceuticals PLC [DPH LN]June 6, 2023 | finance.yahoo.comForm 8.3 - Dechra PharmaceuticalsJune 6, 2023 | finance.yahoo.comForm 8.3 - DPH LNJune 5, 2023 | finance.yahoo.comEQT ups bet on pet industry with $5.6 bln Dechra dealJune 3, 2023 | reuters.comThe Dechra share price holds a lesson for all investors!June 2, 2023 | msn.comDeutsche Reiterates Dechra Pharmaceuticals (LSE:DPH) Outperform RecommendationMay 28, 2023 | msn.comForm 8.3 - DECHRA PHARMAMay 26, 2023 | finance.yahoo.comEuropean stocks muted as U.S. debt ceiling concerns lingerMay 24, 2023 | msn.comUK's Dechra slumps after profit warningMay 23, 2023 | msn.comUK's Dechra down after profit warningMay 22, 2023 | reuters.comMedicine and Biotech Sector Regulatory NewsMay 18, 2023 | lse.co.ukForm 8.3 - GB0009633180 - Dechra Pharmaceuticals PLCMay 9, 2023 | finance.yahoo.comForm 8.3 - GB0009633180May 3, 2023 | finance.yahoo.comForm 8.3 - DECHRA PHARMA - GB0009633180April 25, 2023 | finance.yahoo.comForm 8.3 - Dechra Pharmaceuticals PLCApril 14, 2023 | finance.yahoo.comUK Veterinary Drugmaker Dechra Pharma In Discussions With Private Equity For £5B TakeoverApril 14, 2023 | finance.yahoo.comWhy is the Dechra Pharmaceuticals share price soaring?April 14, 2023 | msn.comVeterinary Drugmaker Dechra Pharma in Talks With Swedish Firm Over £4.6 Billion TakeoverApril 14, 2023 | finance.yahoo.com Get Dechra Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DPH and its competitors with MarketBeat's FREE daily newsletter. Email Address DPH Media Mentions By Week DPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DPH News Sentiment▼0.000.70▲Average Medical News Sentiment DPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DPH Articles This Week▼00▲DPH Articles Average Week Get Dechra Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DPLM News Today HWDN News Today IGG News Today CTY News Today SMWH News Today GNS News Today KYGA News Today CAR News Today AUK News Today PET News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:DPH) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dechra Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Dechra Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.